{"id":21849,"date":"2013-01-01T11:40:35","date_gmt":"2013-01-01T11:40:35","guid":{"rendered":"https:\/\/patientbloodmanagement.org\/resources\/estudio-prospectivo-del-uso-de-eritropoyetina-sobre-la-calidad-de-vida-y-la-rentabilidad-en-pacientes-con-leucemia-mieloide-aguda-y-trasplante-alogenico-de-celulas-madre-hematopoyeticas\/"},"modified":"2024-06-05T20:04:52","modified_gmt":"2024-06-05T20:04:52","slug":"estudio-prospectivo-del-uso-de-eritropoyetina-sobre-la-calidad-de-vida-y-la-rentabilidad-en-pacientes-con-leucemia-mieloide-aguda-y-trasplante-alogenico-de-celulas-madre-hematopoyeticas","status":"publish","type":"resources","link":"https:\/\/patientbloodmanagement.org\/es\/resources\/estudio-prospectivo-del-uso-de-eritropoyetina-sobre-la-calidad-de-vida-y-la-rentabilidad-en-pacientes-con-leucemia-mieloide-aguda-y-trasplante-alogenico-de-celulas-madre-hematopoyeticas\/","title":{"rendered":"Estudio prospectivo del uso de eritropoyetina sobre la calidad de vida y la rentabilidad en pacientes con leucemia mieloide aguda y trasplante alog\u00e9nico de c\u00e9lulas madre hematopoy\u00e9ticas."},"content":{"rendered":"\n<p>Michallet M, Goldet K, Sobh M, Morisset S, Chelghoum Y, Thomas X, Barraco F, Ducastelle S, Labussi\u00e8re H, Renzullo C, Paillet C, Pivot C, Straaten PB, Denis A, Termoz A, Detrait M, Nicolini FE, Jaisson-Hot I. Cancer. 2013 Ene 1;119(1):107-14. doi: 10.1002\/cncr.27686. Epub 2012 Jun 28.<\/p>\n\n<p>Unidad de Trasplante de Sangre y M\u00e9dula \u00d3sea, Departamento de Hematolog\u00eda, Centre Hospitalier Lyon Sud, Pierre B\u00e9nite, Francia.<\/p>\n\n<p><a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22744794\" target=\"_blank\" rel=\"noopener\">Resumen<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Michallet M, Goldet K, Sobh M, Morisset S, Chelghoum Y, Thomas X, Barraco F, Ducastelle S, Labussi\u00e8re H, Renzullo C, Paillet C, Pivot C, Straaten PB, Denis A, Termoz A, Detrait M, Nicolini FE, Jaisson-Hot I. Cancer. 2013 Ene 1;119(1):107-14. doi: 10.1002\/cncr.27686. Epub 2012 Jun 28. Unidad de Trasplante de Sangre y M\u00e9dula \u00d3sea, Departamento <a href=\"https:\/\/patientbloodmanagement.org\/es\/resources\/estudio-prospectivo-del-uso-de-eritropoyetina-sobre-la-calidad-de-vida-y-la-rentabilidad-en-pacientes-con-leucemia-mieloide-aguda-y-trasplante-alogenico-de-celulas-madre-hematopoyeticas\/\">[&#8230;]<\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"template":"","categories":[218],"tags":[],"class_list":["post-21849","resources","type-resources","status-publish","hentry","category-hematologia-oncologia"],"acf":[],"_links":{"self":[{"href":"https:\/\/patientbloodmanagement.org\/es\/wp-json\/wp\/v2\/resources\/21849","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/patientbloodmanagement.org\/es\/wp-json\/wp\/v2\/resources"}],"about":[{"href":"https:\/\/patientbloodmanagement.org\/es\/wp-json\/wp\/v2\/types\/resources"}],"author":[{"embeddable":true,"href":"https:\/\/patientbloodmanagement.org\/es\/wp-json\/wp\/v2\/users\/1"}],"wp:attachment":[{"href":"https:\/\/patientbloodmanagement.org\/es\/wp-json\/wp\/v2\/media?parent=21849"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/patientbloodmanagement.org\/es\/wp-json\/wp\/v2\/categories?post=21849"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/patientbloodmanagement.org\/es\/wp-json\/wp\/v2\/tags?post=21849"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}